Armata Pharmaceuticals (ARMP) Receivables - Net (2016 - 2023)
Quarterly results put Receivables - Net at $300000.0 for Q4 2023, down 84.5% from a year ago — trailing twelve months through Dec 2023 was $300000.0 (down 84.5% YoY), and the annual figure for FY2023 was $300000.0, down 84.5%.
Armata Pharmaceuticals has reported Receivables - Net over the past 9 years, most recently at $300000.0 for Q4 2023.
- Receivables - Net reached $300000.0 in Q4 2023 per ARMP's latest filing, down from $1.3 million in the prior quarter.
- Across five years, Receivables - Net topped out at $3.0 million in Q4 2021 and bottomed at $300000.0 in Q4 2023.
- Median Receivables - Net over the past 4 years was $1.2 million (2022), compared with a mean of $1.3 million.
- The largest annual shift saw Receivables - Net surged 432.8% in 2021 before it plummeted 84.5% in 2023.
- Over 4 years, Receivables - Net stood at $561000.0 in 2020, then soared by 432.8% to $3.0 million in 2021, then crashed by 35.23% to $1.9 million in 2022, then tumbled by 84.5% to $300000.0 in 2023.
- Business Quant data shows Receivables - Net for ARMP at $300000.0 in Q4 2023, $1.3 million in Q1 2023, and $1.9 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 300,000.00 |
| Dec 31, 2023 | 300,000.00 |
| Mar 31, 2023 | 1.26 Mn |
| Mar 31, 2023 | 1.26 Mn |
| Dec 31, 2022 | 1.94 Mn |
| Dec 31, 2022 | 1.94 Mn |
| Sep 30, 2022 | 1.87 Mn |
| Sep 30, 2022 | 1.87 Mn |
| Jun 30, 2022 | 1.88 Mn |
| Jun 30, 2022 | 1.88 Mn |
| Mar 31, 2022 | 1.24 Mn |
| Mar 31, 2022 | 1.24 Mn |
| Dec 31, 2021 | 2.99 Mn |
| Dec 31, 2021 | 2.99 Mn |
| Sep 30, 2021 | 1.25 Mn |
| Sep 30, 2021 | 1.25 Mn |
| Jun 30, 2021 | 1.17 Mn |
| Jun 30, 2021 | 1.17 Mn |
| Mar 31, 2021 | 1.13 Mn |
| Mar 31, 2021 | 1.13 Mn |
| Dec 31, 2020 | 561,000.00 |
| Dec 31, 2020 | 561,000.00 |
| Sep 30, 2020 | 335,000.00 |
| Sep 30, 2020 | 335,000.00 |
| Mar 31, 2020 | 1.00 Mn |
| Mar 31, 2020 | 1.00 Mn |
| Mar 31, 2017 | 15,000.00 |
| Mar 31, 2017 | 15,000.00 |
| Dec 31, 2016 | 12,000.00 |
| Dec 31, 2016 | 12,000.00 |
| Sep 30, 2016 | 24,000.00 |
| Sep 30, 2016 | 24,000.00 |
| Jun 30, 2016 | 18,000.00 |
| Jun 30, 2016 | 18,000.00 |